ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0445

Evaluating Clinical Reasoning in Randomized Surveys of Lupus Nephritis and Preeclampsia Pregnancy Case Workups: A Clinical Conundrum

Liya Stolyar1, Sadaf Sediqi2, Richard Lafayette3, Maurice Druzin4, Saadiya Hawa5, Amanda Moyer6, Yashaar Chaichian2 and Julia Simard2, 1Palo Alto VA Medical Center/Stanford, Stanford, CA, 2Stanford School of Medicine, Stanford, CA, 3Stanford, Stanford, CA, 4Stanford University School of Medicine, Stanford, CA, 5Weiss Memorial Hospital, Chicago, IL, 6Stanford University, San Bruno, CA

Meeting: ACR Convergence 2024

Keywords: Lupus nephritis, pregnancy, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) pregnancy is associated with a heightened risk of adverse pregnancy outcomes, including preeclampsia. Distinguishing preeclampsia from lupus nephritis (LN) presents a diagnostic conundrum due to overlapping signs and symptoms. Furthermore, the treatment approach differs significantly, with early delivery often indicated for the former, while additional immunosuppression is typical for the latter. To address this challenge, we aimed to elucidate the decision-making dynamics of healthcare specialists, specifically obstetricians/gynecologists (OBGYNs), rheumatologists, and nephrologists, regarding multiple SLE pregnancy scenarios.

Methods: We designed clinical vignettes of 5 SLE pregnancies to simulate real-world scenarios. Within each vignette, we coded the instrument to randomly modify up to two features upon presentation (e.g., history of LN) to assess diagnostic inclinations. These case vignettes were included in a survey distributed to OBGYNs, rheumatologists, and nephrologists in the United States, yielding 359 respondents who provided demographic information and completed at least one vignette. This study compares diagnostic responses across medical specialties and vignette types—specifically LN, preeclampsia, and an ambiguous case—to examine how a history of LN influences diagnostic decisions. Statistical analysis included descriptive summaries of respondent characteristics, proportions of specified diagnoses by vignette type and specialty, and frequencies of write-ins for next diagnostic or therapeutic action and degree of certainty.

Results: Participants showed varying accuracy in diagnosing LN and preeclampsia across three vignettes in the presence and absence of LN history and additional modified characteristics. Nephrologists (70.8-84.2%), followed by rheumatologists (58.6-82.4%), were most likely to correctly diagnose LN, regardless of which variables were modified (Table 2). When diagnosing preeclampsia, OBGYNs displayed the highest proficiency (69.2-97.6%), followed by rheumatologists (75-95%). Regardless of the final diagnosis accuracy, most therapeutic and diagnostic next- step recommendations were consistent with those typically advised for LN or preeclampsia, with modest confidence levels overall.

Conclusion: Diagnostic decision-making dynamics among specialty physicians when dealing with LN and preeclampsia during SLE pregnancies are incompletely understood. Using a novel vignette-based approach, we identified specialist-specific diagnostic tendencies that provide insights into this important issue. By investigating these distinctions, we hope to encourage an even greater multidisciplinary approach to this clinical conundrum and ultimately improve patient care.

Supporting image 1

Table 1. Characteristics

Supporting image 2


Disclosures: L. Stolyar: None; S. Sediqi: None; R. Lafayette: None; M. Druzin: None; S. Hawa: None; A. Moyer: None; Y. Chaichian: Amgen, 5, Eli Lilly, 5; J. Simard: None.

To cite this abstract in AMA style:

Stolyar L, Sediqi S, Lafayette R, Druzin M, Hawa S, Moyer A, Chaichian Y, Simard J. Evaluating Clinical Reasoning in Randomized Surveys of Lupus Nephritis and Preeclampsia Pregnancy Case Workups: A Clinical Conundrum [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/evaluating-clinical-reasoning-in-randomized-surveys-of-lupus-nephritis-and-preeclampsia-pregnancy-case-workups-a-clinical-conundrum/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-clinical-reasoning-in-randomized-surveys-of-lupus-nephritis-and-preeclampsia-pregnancy-case-workups-a-clinical-conundrum/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology